Zobrazeno 1 - 10
of 401
pro vyhledávání: '"Krikelis D"'
Autor:
Golfinopoulos, V., Pentheroudakis, G., Goussia, A., Siozopoulou, V., Bobos, M., Krikelis, D., Cervantes, A., Ciuleanu, T., Marselos, M., Fountzilas, G., Malamou-Mitsi, V., Pavlidis, N. *
Publikováno v:
In Annals of Oncology October 2012 23(10):2725-2730
Autor:
Krikelis, D., Tzimagiorgis, G., Georgiou, E., Destouni, C., Agorastos, T., Haitoglou, C., Kouidou, S.
Publikováno v:
In Journal of Clinical Virology 2010 49(3):169-174
Autor:
Tampaki, E.C. Tampakis, A. Alifieris, C.E. Krikelis, D. Pazaiti, A. Kontos, M. Trafalis, D.T.
Background: In the era of personalized therapy, targeted treatment in specific patient populations is mandated. Objective: We evaluated the efficacy and safety of neoadjuvant treatment on locally advanced breast cancer (LABC) with a monoclonal agent
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2127::b87b7cda3a15b3bb4b2bbc4010dc9996
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3123250
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3123250
Autor:
Pentheroudakis, George, Pavlidis, Nicholas, Fountzilas, George, Krikelis, D., Goussia, Anna, Stoyianni, A., Sanden, M., Cyr, B. St, Yerushalmi, N., Benjamin, H., Meiri, E., Chajut, A., Rosenwald, S., Aharonov, R., Spector, Y.
Publikováno v:
Molecular Cancer
Background Cancer of unknown or uncertain primary is a major diagnostic and clinical challenge, since identifying the tissue-of-origin of metastases is crucial for selecting optimal treatment. MicroRNAs are a family of non-coding, regulatory RNA mole
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a4087956a9610396978ea4dcf991e1ce
https://pubmed.ncbi.nlm.nih.gov/23758919
https://pubmed.ncbi.nlm.nih.gov/23758919
Autor:
Krikelis, D., Pentheroudakis, George, Goussia, Anna, Siozopoulou, V., Bobos, M., Petrakis, Dimitrios, Stoyianni, A., Golfinopoulos, Vassilis, Cervantes, A., Ciuleanu, T., Fountzilas, George, Malamou-Mitsi, Vassiliki D., Pavlidis, Nicholas
Publikováno v:
Clinical and Experimental Metastasis
Cancer of unknown primary (CUP) is a heterogeneous entity, managed on the basis of "one size fits all" therapeutic concepts; insights into the molecular biology of CUP are urgently needed. We retrospectively examined the immunohistochemical (IHC) exp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::70cf857a31e444f2522b8fb61a09e607
https://gnosis.library.ucy.ac.cy/handle/7/42055
https://gnosis.library.ucy.ac.cy/handle/7/42055
Autor:
Stoyianni, A., Goussia, Anna, Pentheroudakis, George, Siozopoulou, V., Ioachim, E., Krikelis, D., Golfinopoulos, Vassilis, Cervantes, A., Bobos, M., Fotsis, T., Bellou, S., Fountzilas, George, Malamou-Mitsi, Vassiliki D., Pavlidis, Nicholas
Publikováno v:
Anticancer Research
Background: The epithelial to mesenchymal transition (EMT) has been associated with metastatic dissemination and poor outcome in several solid tumour types. Our aim was to study its incidence and its prognostic significance in cancer of unknown prima
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______4485::119911f3911b9d9070f72cccf76c4691
https://gnosis.library.ucy.ac.cy/handle/7/41784
https://gnosis.library.ucy.ac.cy/handle/7/41784
Autor:
Rashad, Heba M.1 (AUTHOR), Ahmed, Hanan1 (AUTHOR), Mohamed, Samar N.2 (AUTHOR) samarnasef9090@gmail.com, Eleleimy, Hiam A.3 (AUTHOR), Abdel-Aal, Ebtehal M.1 (AUTHOR)
Publikováno v:
Egyptian Journal of Chest Diseases & Tuberculosis. Jul-Sep2024, Vol. 73 Issue 3, p290-301. 12p.
Publikováno v:
Cancer treatment reviews
Introduction: The comparison of clinical cancer research characteristics across the Atlantic and their evolution over time have not been studied to date. Methods: We collected oral presentations on breast, lung and colorectal cancer at ASCO (n = 506)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b44a479545b4fd9d8310417378f6ec76
http://olympias.lib.uoi.gr/jspui/handle/123456789/19034
http://olympias.lib.uoi.gr/jspui/handle/123456789/19034
Autor:
Tampaki EC; Second Department Propaedeutic Surgery, 'Laikon' General Hospital of Athens, National and Kapodistrian University of Athens, Athens, Greece., Tampakis A; Second Department Propaedeutic Surgery, 'Laikon' General Hospital of Athens, National and Kapodistrian University of Athens, Athens, Greece.; Department of Visceral Surgery, Basel University Hospital, Basel, Switzerland., Alifieris CE; Department of Pharmacology, Medical School, National and Kapodistrian University of Athens, 75 Mikras Asias, Goudi, 11527, Athens, Greece. alifieris.k@gmail.com.; Department of Medical Oncology, 'Henry Dunant' Hospital Center, Athens, Greece. alifieris.k@gmail.com.; Department of Surgery, General Hospital of Nea Ionia 'Agia Olga-Konstantopouleion', Athens, Greece. alifieris.k@gmail.com., Krikelis D; Department of Pharmacology, Medical School, National and Kapodistrian University of Athens, 75 Mikras Asias, Goudi, 11527, Athens, Greece., Pazaiti A; Breast Unit, 'Bioclinic' General Clinic of Athens, Athens, Greece., Kontos M; First Department of Surgery, 'Laikon' General Hospital of Athens, National and Kapodistrian University of Athens, Athens, Greece., Trafalis DT; Department of Pharmacology, Medical School, National and Kapodistrian University of Athens, 75 Mikras Asias, Goudi, 11527, Athens, Greece.; Department of Medical Oncology, 'Henry Dunant' Hospital Center, Athens, Greece.
Publikováno v:
Clinical drug investigation [Clin Drug Investig] 2018 Jul; Vol. 38 (7), pp. 639-648.